Retatrutide is an investigational triple incretin receptor agonist under clinical development by Eli Lilly, whilst 5-Amino-1MQ is a research chemical targeting the NNMT enzyme
However, if you have insulin resistance or diabetes, you should still monitor blood sugar closely and consult a healthcare provider before use
No dose-escalation or maximum tolerated dose studies have been conducted, limiting understanding of safety at higher doses
Confirm below to continue
Based on these observations, the researchers commented, The present study proposed that AHK-Cu promotes the growth of [...] hair follicles, and this stimulatory effect may occur due to stimulation of the proliferation and the preclusion of the apoptosis of DPCs. (4)
This timeframe allows assessment of individual response, opportunity to adjust dosing, and generation of meaningful results without committing to an extended protocol